Chemical Hematology: breaking resistance of hematological malignancies through personalized drug trials

Project Information

chemos

Grant agreement ID: 727416

DOI 10.3030/727416

Project closed

EC signature date 23 September 2016

Start date 1 October 2016

End date 30 September 2017

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 146 668,00

EU contribution € 146 668,00

Coordinated by

CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH
Austria

Publications

Peer reviewed articles (1)

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study

Author(s): Berend Snijder, Gregory I Vladimer, Nikolaus Krall, Katsuhiro Miura, Ann-Sofie Schmolke, Christoph Kornauth, Oscar Lopez de la Fuente, Hye-Soo Choi, Emiel van der Kouwe, Sinan Gültekin, Lukas Kazianka, Johannes W Bigenzahn, Gregor Hoermann, Nicole Prutsch, Olaf Merkel, Anna Ringler, Monika Sabler, Georg Jeryczynski, Marius E Mayerhoefer, Ingrid Simonitsch-Klupp, Katharina Ocko, Franz Felberbauer,
Published in: The Lancet Haematology, 2017, ISSN 2352-3026
Publisher: Elsevier Limited
DOI: 10.1016/S2352-3026(17)30208-9

Intellectual Property Rights

Trademark (1)

(C)hemos

Application/Publication number: CM 004EUtm
Date: 2014-11-06

Patent (2)

MONOLAYER OF PBMCS OR BONE-MARROW CELLS AND USES THEREOF

Application/Publication number: PCT/EP 2015/072046
Date: 2015-09-24

MULTIWELL IMAGING PLATE AND METHOD FOR INCUBATING NON-ADHERENT CELLS

Application/Publication number: PCT/EP 2017/060561
Date: 2017-05-03